Investor Relations
Investing in the future of precision oncology
Defence Therapeutics is a publicly traded Canadian biotechnology company committed to making cancer treatment more effective and safer. Using its Accum® precision drug delivery platform, Defence is working to enhance the potency of ADCs and other complex biologics at lower doses, with the goal of reducing side effects and improving access to advanced therapies. By pursing cutting edge science, and collaborating with pharma and biotech partners, Defence strives to bring transformative therapies to patients who need them most.
Investment Highlights
Proprietary Platform Technology
The Accum® platform enhances intracellular drug delivery, boosting potency up to 60-fold while reducing toxicity and treatment costs
Exposure to High-Growth Oncology Segments
Focus on Antibody-Drug Conjugates (ADCs) and radiopharmaceuticals, two of the fastest-growing oncology markets, validated by multi-billion-dollar acquisitions
De-risked Licensing Model
Near-term revenue potential through licensing, milestones, and royalties, while partners bear the cost and risk of clinical trials.
Robust Intellectual Property
7 patent families and 6 issued US patents provide broad protection across ADCs, radiopharma, and other biologics.
Strategic Collaborations
- Active collaboration with leading national radiopharmaceutical group to develop multiple novel radioimmune conjugate assets
- Exploring co-development partnership with multiple partners to accelerate the development
Experienced Global Leadership
Management team and advisors combine deep expertise in oncology, pharma partnerships, regulatory strategy, and capital markets.
Investor Relations
Reach out to our team for corporate, financial, or partnership inquiries
We welcome inquiries from investors, analysts, and partners who want to learn more about
Defence Therapeutics and the Accum® platform.
Defence Therapeutics Inc.
7171 Frederick Banting Street,
Montreal, QC, H4S 1Z9
Canada
Phone: +1 (514) 947 – 2272
Email: info@defencetherapeutics.com